Merlin26 wrote:My neuro believes that Tim does work for Opexa and is being paid by them to advertise his story.
One thing we do know is that Tim's father does work for Opexa and was one of the principle investors that got the company going. Whether or not Tim works for Opexa is probably unknown to the general public.
The Phase II trial data only covered 18 people and those were the 18 that my neuro met with and saw courtesy of Opexa.
That was actually a Phase IB/IIA trial which was open label.
I can't really say one way or the other how well it's going to work until I see the Phase III trial data.
The current trial is Phase IIB, is double blind, and includes 150 patients if I remember correctly. A Phase III trial is still sometime off in the future assuming that the IIB trial goes well.